Stemson Therapeutics is a pre-clinical stage cell therapy company founded in 2018 with a mission to cure hair loss by leveraging the regenerative power of Induced Pluripotent Stem Cells (iPSC). We use the iPSC-derived cells to grow de novo hair follicles, offering a new supply of hair to treat people suffering from various forms of Alopecia.